文献速递急性肾损伤慢性肾脏病

抗生素耗竭肠道菌群通过抑制NOX2和TMAO减轻AKI向CKD转化

Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition.
PubMed 文献 · Kidney Int · 2024-02-29

该研究在61例AKI患者中分析血浆代谢物与AKI向CKD转化的风险,发现TMAO与转化风险显著增加相关(调整OR 4.389,95%CI 1.106-17.416)。小鼠单侧缺血再灌注损伤模型中,抗生素诱导的菌群耗竭可抑制TMAO升高并减轻凋亡、炎症和纤维化,其机制涉及NOX2激活和氧化应激,体外实验验证TMAO通过NOX2促进纤维化。

要点

  • 血浆TMAO水平与AKI向CKD转化风险显著增加相关。
  • 抗生素耗竭肠道菌群可减轻小鼠AKI后向CKD的转化。
  • NOX2激活是TMAO相关AKI向CKD转化的关键调节因子。

核心结论

  • TMAO是与AKI向CKD转化相关的关键代谢物,NOX2激活是TMAO相关AKI向CKD转化的关键调节因子。

研究设计与样本

  • 临床队列纳入61例AKI患者,检测59种血浆代谢物以确定AKI向CKD转化的风险。
  • 建立小鼠单侧缺血再灌注损伤后4周的AKI向CKD转化模型,评估抗生素诱导的菌群耗竭对肠道菌群、代谢物和病理反应的影响。
  • 体外用CKD转化相关代谢物刺激人近端小管上皮细胞,并测试NOX2信号的抑制作用。

主要发现

  • 在61例AKI患者中,血浆TMAO与AKI向CKD转化风险显著增加相关(调整OR 4.389,95%CI 1.106-17.416)。
  • 体内实验中,抗生素诱导的菌群耗竭抑制了单侧缺血再灌注损伤引起的TMAO升高,并减少凋亡、炎症和纤维化。
  • 抗生素诱导的菌群耗竭后NOX2表达和氧化应激降低。
  • 体外实验中,TMAO通过激活NOX2和氧化应激诱导纤维化。
  • 抑制NOX2可减轻凋亡、炎症和纤维化,并抑制G2/M期阻滞;体内抑制NOX2可改善病理变化并降低氧化应激,而不改变TMAO水平。

临床怎么用

  • 血浆TMAO可能作为评估AKI向CKD转化风险的代谢标志物。
  • 靶向肠道菌群或NOX2通路可能为减轻AKI向CKD转化提供潜在干预策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Intestinal microbiota and their metabolites affect systemic inflammation and kidney disease outcomes. Here, we investigated the key metabolites associated with the acute kidney injury (AKI)-to chronic kidney disease (CKD) transition and the effect of antibiotic-induced microbiota depletion (AIMD) on this transition. In 61 patients with AKI, 59 plasma metabolites were assessed to determine the risk of AKI-to-CKD transition. An AKI-to-CKD transition murine model was established four weeks after unilateral ischemia-reperfusion injury (IRI) to determine the effects of AIMD on the gut microbiome, metabolites, and pathological responses related to CKD transition. Human proximal tubular epithelial cells were challenged with CKD transition-related metabolites, and inhibitory effects of NADPH oxidase 2 (NOX2) signals were tested. Based on clinical metabolomics, plasma trimethylamine N-oxide (TMAO) was associated with a significantly increased risk for AKI-to-CKD transition [adjusted odds ratio 4.389 (95% confidence interval 1.106-17.416)]. In vivo, AIMD inhibited a unilateral IRI-induced increase in TMAO, along with a decrease in apoptosis, inflammation, and fibrosis. The expression of NOX2 and oxidative stress decreased after AIMD. In vitro, TMAO induced fibrosis with NOX2 activation and oxidative stress. NOX2 inhibition successfully attenuated apoptosis, inflammation, and fibrosis with suppression of G2/M arrest. NOX2 inhibition (in vivo) showed improvement in pathological changes with a decrease in oxidative stress without changes in TMAO levels. Thus, TMAO is a key metabolite associated with the AKI-to-CKD transition, and NOX2 activation was identified as a key regulator of TMAO-related AKI-to-CKD transition both in vivo and in vitro.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Lee J, Lee J, Kim K, et al. Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition. Kidney Int. 2024. PMID: 38431216. doi:10.1016/j.kint.2024.01.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。